Financhill
Back

Intellia Therapeutics Vs. Nuvalent Industry Stock Comparison

Sell
14

NTLA
Intellia Therapeutics

Last Price:
$9.50
Seasonality Move:
-6.53%
Sell
31

NUVL
Nuvalent

Last Price:
$75.84
Seasonality Move:
-10.54%
Sell
14
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $9.50. The Score for NTLA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

  • The current Nuvalent [NUVL] share price is $75.84. The Score for NUVL is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • NUVL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $9.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

  • The Nuvalent share price today is $75.84
    The current trend is relatively stagnant and NUVL is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 27.37 Sell
Chaikin Money Flow: -78316 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.51 - 13.09) Sell
Bollinger Bands (100): (12.69 - 20.51) Sell

NUVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.66 Sell
Relative Strength Index (14 RSI): 38.1 Sell
Chaikin Money Flow: 19199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.05 - 86.15) Sell
Bollinger Bands (100): (82.61 - 100.51) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.39 Sell
20-day SMA: 11.39 Sell
50-day SMA: 13.42 Sell
200-day SMA: 20.23 Sell
8-day EMA: 10.23 Sell
20-day EMA: 11.34 Sell
50-day EMA: 13.33 Sell
200-day EMA: 19.74 Sell

NUVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.06 Sell
20-day SMA: 79.23 Sell
50-day SMA: 87.14 Sell
200-day SMA: 82.32 Sell
8-day EMA: 76.34 Sell
20-day EMA: 79.52 Sell
50-day EMA: 84.88 Sell
200-day EMA: 82.76 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.41 per share.

Nuvalent Earnings Growth & NUVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.12 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nuvalent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):